$CME

CME Group Q3 revenue hits record $1.74B, beating estimates (CME:NASDAQ)

CME Group reported Q3 revenue of $1.74B, up 13% year-over-year, exceeding estimates. Non-GAAP EPS was $3.02, beating by $0.03. Adjusted net income rose 12.1% to $1.08B, with average daily volume hitting a Q3 record of 29.4M.

Original reporting
Published Oct 21, 2026, 11:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat signals robust demand for futures and options, supporting a bullish outlook for the firm.

02

Market read

Strong Q3 results may drive short‑term buying in CME and positively influence related financial stocks.

03

What to watch

Potential headwinds from regulatory scrutiny of derivatives markets or slower futures volume growth.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

CME Group is the world's largest derivatives exchange, and its earnings are closely watched for insights into market activity.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 revenue of $1.74B, a 13% YoY increase, beating estimates and posting a Non‑GAAP EPS of $3.02.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The beat on both revenue and EPS for a large‑cap exchange operator typically triggers buying interest.

Market effects

Positive earnings may lift the broader financial services and exchange‑operator sector.

U.S. markets could see a modest boost in financial stocks.

CME's global clearing services mean the beat could reinforce confidence in derivatives markets worldwide.

Counterpoint

If the beat is already priced in, the stock could face short‑covering pull‑back.

Key entities

  • CME Group Inc.

    Leading global derivatives exchange operator.

Related articles

$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.